LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 42.67 | 771.67 | 3265 | 5155 | 0.6333 | 0.6929 | MN20160304_L01 | I21 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 44.89 | 771.67 | 3105 | 5541 | 0.5603 | 0.6315 | MN20160304_L01 | E20 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 44.89 | 771.67 | 3036 | 5541 | 0.5479 | 0.6186 | MN20160304_L01 | H05 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 44.89 | 771.67 | 3448 | 5541 | 0.6222 | 0.6927 | MN20160304_L01 | I21 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 47.11 | 771.67 | 3313 | 5941 | 0.5576 | 0.6402 | MN20160304_L01 | E20 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 47.11 | 771.67 | 3270 | 5941 | 0.5504 | 0.6329 | MN20160304_L01 | H05 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 47.11 | 771.67 | 3682 | 5941 | 0.6197 | 0.7000 | MN20160304_L01 | I21 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 49.33 | 771.67 | 3490 | 6392 | 0.5459 | 0.6401 | MN20160304_L01 | E20 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 49.33 | 771.67 | 3447 | 6392 | 0.5392 | 0.6334 | MN20160304_L01 | H05 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 49.33 | 771.67 | 3923 | 6392 | 0.6137 | 0.7042 | MN20160304_L01 | I21 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 51.55 | 771.67 | 3708 | 6829 | 0.5429 | 0.6471 | MN20160304_L01 | E20 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 51.55 | 771.67 | 3578 | 6829 | 0.5239 | 0.6285 | MN20160304_L01 | H05 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 51.55 | 771.67 | 4066 | 6829 | 0.5953 | 0.6960 | MN20160304_L01 | I21 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 53.77 | 771.67 | 3991 | 7256 | 0.5500 | 0.6624 | MN20160304_L01 | E20 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 53.77 | 771.67 | 3902 | 7256 | 0.5377 | 0.6508 | MN20160304_L01 | H05 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 53.77 | 771.67 | 4467 | 7256 | 0.6156 | 0.7213 | MN20160304_L01 | I21 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 55.99 | 771.67 | 4192 | 7690 | 0.5451 | 0.6657 | MN20160304_L01 | E20 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 55.99 | 771.67 | 4051 | 7690 | 0.5268 | 0.6486 | MN20160304_L01 | H05 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 55.99 | 771.67 | 4706 | 7690 | 0.6120 | 0.7248 | MN20160304_L01 | I21 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 58.21 | 771.67 | 4434 | 8085 | 0.5484 | 0.6751 | MN20160304_L01 | E20 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 58.21 | 771.67 | 4268 | 8085 | 0.5279 | 0.6564 | MN20160304_L01 | H05 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 58.21 | 771.67 | 4866 | 8085 | 0.6018 | 0.7217 | MN20160304_L01 | I21 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 60.44 | 771.67 | 4665 | 8530 | 0.5469 | 0.6804 | MN20160304_L01 | E20 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 60.44 | 771.67 | 4543 | 8530 | 0.5326 | 0.6676 | MN20160304_L01 | H05 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 60.44 | 771.67 | 5165 | 8530 | 0.6055 | 0.7305 | MN20160304_L01 | I21 |